Patent ID: 7964603

Claim:
A tetrahydro-quinoline-sulfonamide of general formula (I) wherein R 1 , R 2 and R 3 , independent from one another, each represent a hydrogen atom; or a linear or branched, saturated or unsaturated C 1-6 aliphatic radical which may be substituted with 1, 2 or 3 substituent(s) independently selected from the group consisting of F, Cl, Br, —OH, —O—CH 3 , —O—C 2 H 5 , —CN with the proviso that at least one of R 1 , R 2 and R 3 is a C 1-6 alkyl group optionally substituted with 1, 2 or 3 substituent(s) as defined above; R 4 , R 5 and R 6 , independent from one another, each represent a hydrogen atom or a chlorine atom; R 7 represents a hydrogen atom; or a linear or branched, saturated or unsaturated C 1-6 aliphatic radical which may be substituted with 1, 2 or 3 substituent(s) independently selected from the group consisting of F, —OH, —O—CH 3 and —O—C 2 H 5 ; and R 8 represents a 6- to 10-membered aryl radical which may be substituted with 1, 2 or 3 substituent(s) independently selected from the group consisting of —CH 3 , —C 2 H 5 , Cl, Br, —OH, —NH 2 , —SH, —O—CH 3 , —O—C 2 H 5 , —NO 2 , —CN, —NH—CH 3 and —S—CH 3 ; optionally in form of one of its stereoisomers, a racemate or in form of a mixture of at least two of its stereoisomers, in any mixing ratio, or a physiologically acceptable salt, thereof.